通过IMMA的基质选择性COX-2抑制通过内分泌大麻素调节和神经炎症抑制减轻创伤后头痛
Jie Wen1, Mikiei Tanaka1, Yumin Zhang2
1Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA.
The journal of headache and pain
|August 13, 2025
概括
印美甲形胺 (IMMA) 在小鼠创伤性脑损伤 (TBI) 后减少疼痛和神经炎症. 这种新的治疗方法可以增强内分泌大麻素信号传递,而不会破坏必需的前列腺素.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 创伤后头痛 (PTH) 是创伤性脑损伤 (TBI) 的常见,使人虚弱的后果.
- 目前的PTH治疗方法有限,需要新的治疗策略.
- 印美甲胺基 (IMMA) 通过增强内分泌大麻素信号传递,提供了一种独特的方法.
研究的目的:
- 在重复轻度TBI (rmTBI) 的动物模型中评估IMMA的疗效.
- 在rmTBI中评估IMMA对神经炎症和疼痛过敏的影响.
- 研究IMMA的作用机制,涉及内分泌大麻素和前列腺素通路.
主要方法:
- 雄性C57BL/6J小鼠使用CHIMERA模型接受了rmTBI.
- 在受伤后的7天内,小鼠每天接受IMMA治疗 (10mg/kg).
- 评估了外围轨道机械体,神经炎症 (微细胞,星球细胞,CGRP),巨细胞完整性,以及阿南胺 (AEA) 和前列腺素E2 (PGE2) 的水平.
主要成果:
- IMMA显著降低了rmTBI诱导的三角质核中的外周全体和神经炎症.
- IMMA保留了脑膜巨细胞的完整性.
- 在保持前列腺素E2 (PGE2) 水平的同时,IMMA提高了皮质胺 (AEA) 水平,这表明在不抑制前列腺素的情况下增强了大麻素信号传递.
结论:
- 在rmTBI模型中,IMMA有效地减轻了急性神经炎症和疼痛过敏.
- 该药物通过一种机制起作用,该机制可以在不抑制生理性前列腺素的情况下保持内分泌卡纳比诺伊德调.
- IMMA作为PTH的新疗法具有前景,需要在慢性阶段和其他地区进行进一步的研究.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
326
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
326
Analgesia and Pain Management
791
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
791
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366


